• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

RBC Transfusion

Thromboelastometry and Clinical Guidance for Fibrinogen Infusions during Liver Transplantation

Thromboelastometry provides individualized measures of clot kinetics and structure, and has played an increasingly important role in the management of…

February 8, 2023

Sickle Cell Trait Testing of RBC Units

While individuals with the sickle cell trait (SCT) have a single allele of hemoglobin S (HbS) and are eligible blood…

December 27, 2022

Hypoxic Storage Helps to Preserve Red Blood Cells

Red blood cells (RBCs) may be stored for up to 42 days, but over time storage lesions also develop.  These…

November 22, 2022

Transfusion Thresholds for Patients Receiving ECMO

Venovenous extracorporeal membrane oxygenation (ECMO) can be used to help provide respiratory support to patients with severe acute respiratory distress…

November 2, 2022

Sex-Matched Transfusions May Reduce Mortality

While plasma from female donors increases the risk of transfusion-related acute lung injury (TRALI), observational studies have had conflicting results…

October 6, 2022

Mitapivat Trial Results in Adults with Pyruvate Kinase Deficiency Requiring Transfusions

Pyruvate kinase deficiency is a rare, congenital form of chronic hemolytic anemia.  Current treatments for pyruvate kinase deficiency, including RBC…

August 31, 2022

Results from Phase 1 Trial for Artificial Hemoglobin Vesicles

Advantages of artificial red blood cells (RBCs) include reduced risks of pathogens and alloimmunization and greater storage time compared to…

August 24, 2022

Safety and Effectiveness of Tranexamic Acid in Cardiac Surgery Patients

Tranexamic acid is an antifibrinolytic agent that is commonly used to control bleeding in patients undergoing cardiac surgery.  Limited randomized…

August 10, 2022

Racial Differences in Red Blood Cell Transfusions

Transfusion guidelines recommend transfusing red blood cells (RBCs) when hemoglobin (Hb) levels drop below 7 or 8 g/dL, but variation…

August 3, 2022

Hypocalcemia Associated with Increased Transfusion Requirements in Pediatric Trauma Patients

Hypocalcemia (Ca++ <1.1 mmol/L) has recently been identified as a fourth component of the “lethal triad” for mortality of adult…

July 27, 2022

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Interim pages omitted …
  • Page 22
  • Go to Next Page »

Primary Sidebar

Latest News

  • RBC Transfusions to Treat Acute Heavy Menstrual Bleeding

  • RBC Transfusion Outcomes Similar in ICU Patients with and Without Cardiovascular Disease

  • Cryopreserved vs. Standard Platelets for Surgical Bleeding

  • Phosphatidylserine and Phosphatidylethanolamine Levels on RBCs Important for Transfusion Outcomes

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley